The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Reproducible Genetic Risk Loci for Anxiety: Results From ∼200,000 Participants in the Million Veteran Program
Open accessAbstract
We used GWAS in the Million Veteran Program sample (nearly 200,000 informative individuals) using a continuous trait for anxiety (GAD-2) to identify 5 genome-wide significant (GWS) signals for European Americans (EA) and 1 for African Americans. The strongest findings were on chromosome 3 (rs4603973, p=7.40×10 −11 ) near the SATB1 locus, a global regulator of gene expression and on chromosome 6 (rs6557168, p=1.04×10 −9 ) near ESR1 which encodes estrogen receptor α. A locus identified on chromosome 7 near MADIL1 (p=1.62×10 −8 ) has been previously identified in GWAS of bipolar disorder and of schizophrenia and may represent a risk factor for psychiatric disorders broadly. SNP-based heritability was estimated to be ~6% for GAD-2. We also GWASed for self-reported anxiety disorder diagnoses (N=224,330) and identified two GWS loci, one (rs35546597, MAF=0.42, p=1.88×10 −8 ) near the AURKB locus, and the other (rsl0534613, MAF=0.41, p=4.92×10 −8 ) near the IQCHE and MADIL1 locus identified in the GAD-2 analysis. We demonstrate reproducibility by replicating our top findings in the summary statistics from the Anxiety NeuroGenetics Study (ANGST) and a UK Biobank neuroticism GWAS. We also replicated top findings from a large UK Biobank preprint, demonstrating stability of GWAS findings in complex traits once sufficient power is attained. Finally, we found evidence of significant genetic overlap between anxiety and major depression using polygenic risk scores, but also found that the main anxiety signals are independent of those for MDD. This work presents novel insights into the neurobiological risk underpinning anxiety and related psychiatric disorders. Significance Anxiety disorders are common and often disabling. They are also frequently co-morbid with other mental disorders such as major depressive disorder (MDD); these disorders may share commonalities in their underlying genetic architecture. Using one of the largest homogenously phenotyped cohorts available, the Million Veteran Program sample, we investigated common variants associated with anxiety in genome-wide association studies (GWASes), using survey results from the GAD-2 anxiety scale (as a continuous trait, n=199,611), and self-reported anxiety disorder diagnosis (as a binary trait, n=224,330). This largest GWAS to date for anxiety and related traits identified numerous novel significant associations, several of which are replicated in other datasets, and allows inference of underlying biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089
A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-7
Spitzer, R. L., Kroenke, K., Williams, J. B. W., & Löwe, B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1092 · Cited by 31,765
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Self-citationPrincipal components analysis corrects for stratification in genome-wide association studies
Price, A. L., Patterson, N. J., Plenge, R. M., Weinblatt, M. E., Shadick, N. A., & Reich, D. (2006) · Nature Genetics · doi:10.1038/ng1847 · Cited by 10,248
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577 · cited 1×
“43310(214)) (48), andour leadSNP isnominally significant in that study (rs56226325, p=1.”
BackgroundCausal analysis approaches in Ingenuity Pathway Analysis
Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · cited 1×
“05 false discovery rate, identified 189 genes (see Table S3 in the online supplement) in total for investigation of biological relevance through the Ingenuity pathway enrichment tool (32), Ingenuity Pathway Analysis (Ingenuity Systems, Redwood City, Calif.”
MethodAnxiety disorders in primary care: prevalence, impairment, comorbidity, and detection
Kroenke, K., Spitzer, R. L., Williams, J. B. W., Monahan, P. O., & Löwe, B. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-5-200703060-00004 · Cited by 4,741 · cited 1×
“” Although the GAD-2 has demonstrated high sensitivity and specificity for anxiety disorders (52), it falls short of the desired trait (lifetime) anxiety measure.”
BackgroundFunctional mapping and annotation of genetic associations with FUMA
Watanabe, K., Taskesen, E., van Bochoven, A., & Posthuma, D. (2017) · Nature Communications · doi:10.1038/s41467-017-01261-5 · Cited by 4,083
Kroenke, K., Spitzer, R. L., Williams, J. B. W., & Löwe, B. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.03.006 · Cited by 4,057
Systematic Localization of Common Disease-Associated Variation in Regulatory DNA
Maurano, M. T., Humbert, R., Rynes, E., Thurman, R. E., Haugen, E., Wang, H., Reynolds, A. P., Sandstrom, R., Qu, H., Brody, J., et al. (2012) · Science · doi:10.1126/science.1222794 · Cited by 3,716
MAGMA: Generalized Gene-Set Analysis of GWAS Data
de Leeuw, C. A., Mooij, J. M., Heskes, T., & Posthuma, D. (2015) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004219 · Cited by 3,653
eQTLGen, Wray, N. R., 23andMe, the Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium, Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., Adams, M. J., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0090-3 · Cited by 3,005
Self-citationAn Expanded View of Complex Traits: From Polygenic to Omnigenic
Boyle, E. A., Li, Y. I., & Pritchard, J. K. (2017) · Cell · doi:10.1016/j.cell.2017.05.038 · Cited by 2,851
Howard, D. M., Adams, M. J., Clarke, T.-K., Hafferty, J. D., Gibson, J., Shirali, M., Coleman, J. R. I., Hagenaars, S. P., Ward, J., Wigmore, E. M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0326-7 · Cited by 2,565 · cited 1×
“67) (33), and neuroticism by Nagel et al.”
BackgroundSelf-citationAnalysis of shared heritability in common disorders of the brain
The Brainstorm Consortium, Anttila, V., Bulik-Sullivan, B., Finucane, H. K., Walters, R. K., Bras, J., Duncan, L., Escott-Price, V., Falcone, G. J., Gormley, P., et al. (2018) · Science · doi:10.1126/science.aap8757 · Cited by 1,924 · cited 2×
“The Brainstorm Consortium has investigated shared heritability between psychiatric and neurological disorders (51).”
BackgroundSelf-citationPRSice: Polygenic Risk Score software
Euesden, J., Lewis, C. M., & O’Reilly, P. F. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu848 · Cited by 1,191
Million Veteran Program: A mega-biobank to study genetic influences on health and disease
Gaziano, J. M., Concato, J., Brophy, M., Fiore, L., Pyarajan, S., Breeling, J., Whitbourne, S., Deen, J., Shannon, C., Humphries, D., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.09.016 · Cited by 1,055
Self-citationCausal associations between risk factors and common diseases inferred from GWAS summary data
Zhu, Z., Zheng, Z., Zhang, F., Wu, Y., Trzaskowski, M., Maier, R., Robinson, M. R., McGrath, J. J., Visscher, P. M., Wray, N. R., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02317-2 · Cited by 951 · cited 1×
“Conditional Analysis for Major Depression Considering the extensive comorbidity between major depression and anxiety disorders (6), we ran a conditional analysis with the multi-trait-based conditional and joint analysis method (mtCOJO) (27) using the GCTA software package.”
MethodZheng, J., Erzurumluoglu, A. M., Elsworth, B. L., Kemp, J. P., Howe, L., Haycock, P. C., Hemani, G., Tansey, K., Laurin, C., Early Genetics and Lifecourse Epidemiology (EAGLE) Eczema Consortium, et al. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btw613 · Cited by 869
23andMe Research Team, Nagel, M., Jansen, P. R., Stringer, S., Watanabe, K., de Leeuw, C. A., Bryois, J., Savage, J. E., Hammerschlag, A. R., Skene, N. G., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0151-7 · Cited by 799
Self-citationThe global burden of anxiety disorders in 2010
Baxter, A. J., Vos, T., Scott, K. M., Ferrari, A. J., & Whiteford, H. A. (2014) · Psychological Medicine · doi:10.1017/s0033291713003243 · Cited by 768
Craske, M. G., Stein, M. B., Eley, T. C., Milad, M. R., Holmes, A., Rapee, R. M., & Wittchen, H.-U. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.24 · Cited by 652
Response rates for CBT for anxiety disorders: need for standardized criteria
Loerinc, A. G., Meuret, A. E., Twohig, M. P., Rosenfield, D., Bluett, E. J., & Craske, M. G. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.08.004 · Cited by 592
Meta-analysis of genome-wide association studies of anxiety disorders
Otowa, T., Hek, K., Lee, M., Byrne, E. M., Mirza, S. S., Nivard, M. G., Bigdeli, T., Aggen, S. H., Adkins, D., Wolen, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.197 · Cited by 564
Efficacy of treatments for anxiety disorders: a meta-analysis
Bandelow, B., Reitt, M., Röver, C., Michaelis, S., Görlich, Y., & Wedekind, D. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000078 · Cited by 555
Craske, M. G., Rauch, S. L., Ursano, R., Prenoveau, J., Pine, D. S., & Zinbarg, R. E. (2009) · Depression and Anxiety · doi:10.1002/da.20633 · Cited by 529
Psychological treatment of generalized anxiety disorder: A meta-analysis
Cuijpers, P., Sijbrandij, M., Koole, S., Huibers, M., Berking, M., & Andersson, G. (2014) · Clinical Psychology Review · doi:10.1016/j.cpr.2014.01.002 · Cited by 527
Population History and Natural Selection Shape Patterns of Genetic Variation in 132 Genes
Akey, J. M., Eberle, M. A., Rieder, M. J., Carlson, C. S., Shriver, M. D., Nickerson, D. A., & Kruglyak, L. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020286 · Cited by 502
Integrating Functional Data to Prioritize Causal Variants in Statistical Fine-Mapping Studies
Kichaev, G., Yang, W.-Y., Lindstrom, S., Hormozdiari, F., Eskin, E., Price, A. L., Kraft, P., & Pasaniuc, B. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004722 · Cited by 491
Ginzburg, K., Ein-Dor, T., & Solomon, Z. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.08.006 · Cited by 475
Cooke, P. S., Nanjappa, M. K., Ko, C., Prins, G. S., & Hess, R. A. (2017) · Physiological Reviews · doi:10.1152/physrev.00018.2016 · Cited by 466
Duncan, L. E., Ratanatharathorn, A., Aiello, A. E., Almli, L. M., Amstadter, A. B., Ashley-Koch, A. E., Baker, D. G., Beckham, J. C., Bierut, L. J., Bisson, J., et al. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.77 · Cited by 425
Self-citationCognitive-Behavioral and Pharmacological Treatments of Social Phobia: A Controlled Study
Gelernter, C. S. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340070009 · Cited by 404
Haskell, S. G., Gordon, K. S., Mattocks, K., Duggal, M., Erdos, J., Justice, A., & Brandt, C. A. (2010) · Journal of Women's Health · doi:10.1089/jwh.2008.1262 · Cited by 293
Cichon, S., Mühleisen, T. W., Degenhardt, F. A., Mattheisen, M., Miró, X., Strohmaier, J., Steffens, M., Meesters, C., Herms, S., Weingarten, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.01.017 · Cited by 286
Spatiotemporal genomic architecture informs precision oncology in glioblastoma
Lee, J.-K., Wang, J., Sa, J. K., Ladewig, E., Lee, H.-O., Lee, I.-H., Kang, H. J., Rosenbloom, D. S., Camara, P. G., Liu, Z., et al. (2017) · Nature Genetics · doi:10.1038/ng.3806 · Cited by 273
Mental Disorders Top The List Of The Most Costly Conditions In The United States: $201 Billion
Roehrig, C. (2016) · Health Affairs · doi:10.1377/hlthaff.2015.1659 · Cited by 245
Meier, S. M., Trontti, K., Purves, K. L., Als, T. D., Grove, J., Laine, M., Pedersen, M. G., Bybjerg-Grauholm, J., Bækved-Hansen, M., Sokolowska, E., et al. (2019) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.1119 · Cited by 240
Comer, J. S., Blanco, C., Hasin, D. S., Liu, S.-M., Grant, B. F., Turner, J. B., & Olfson, M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05094blu · Cited by 214
Hou, L., Bergen, S. E., Akula, N., Song, J., Hultman, C. M., Landén, M., Adli, M., Alda, M., Ardau, R., Arias, B., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw181 · Cited by 209
Department of Veterans Affairs Cooperative Studies Program (#575B) and Million Veteran Program, Gelernter, J., Sun, N., Polimanti, R., Pietrzak, R., Levey, D. F., Bryois, J., Lu, Q., Hu, Y., Li, B., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0447-7 · Cited by 200
Self-citationWhat Are Polygenic Scores and Why Are They Important?
Sugrue, L. P., & Desikan, R. S. (2019) · JAMA · doi:10.1001/jama.2019.3893 · Cited by 174
Coric, V., Feldman, H. H., Oren, D. A., Shekhar, A., Pultz, J., Dockens, R. C., Wu, X., Gentile, K. A., Huang, S.-P., Emison, E., et al. (2010) · Depression and Anxiety · doi:10.1002/da.20695 · Cited by 172
The anxiolytic effect of the CRH1 receptor antagonist R121919 depends on innate emotionality in rats
Keck, M. E., Welt, T., Wigger, A., Renner, U., Engelmann, M., Holsboer, F., & Landgraf, R. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2000.01383.x · Cited by 166
Zorrilla, E. P., Valdez, G. R., Nozulak, J., Koob, G. F., & Markou, A. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03189-x · Cited by 159
Estrogen Receptors Modulation of Anxiety-Like Behavior
Borrow, A. P., & Handa, R. J. (2017) · Vitamins and Hormones · doi:10.1016/bs.vh.2016.08.004 · Cited by 146 · cited 1×
“Studies of estradiol administration to ovariectomized rats and ESR1 null mice have shown consistent evidence thatESR1 is involved inanxiety-likebehavior (39).”
BackgroundThe cerebellum in fear and anxiety-related disorders
Moreno, J. M. M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.04.002 · Cited by 134
MRM2 and MRM3 are involved in biogenesis of the large subunit of the mitochondrial ribosome
Rorbach, J., Boesch, P., Gammage, P. A., Nicholls, T. J. J., Pearce, S. F., Patel, D., Hauser, A., Perocchi, F., & Minczuk, M. A. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-01-0014 · Cited by 129
Zinbarg, R. E., Mineka, S., Bobova, L., Craske, M. G., Vrshek-Schallhorn, S., Griffith, J. W., Wolitzky-Taylor, K., Waters, A. M., Sumner, J. A., & Anand, D. (2016) · Clinical Psychological Science · doi:10.1177/2167702615618162 · Cited by 123
Balamotis, M. A., Tamberg, N., Woo, Y. J., Li, J., Davy, B., Kohwi-shigematsu, T., & Kohwi, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05917-11 · Cited by 100
Erratum: Meta-analysis of genome-wide association studies of anxiety disorders
Otowa, T., Hek, K., Lee, M., Byrne, E. M., Mirza, S. S., Nivard, M. G., Bigdeli, T. B., Aggen, S. H., Adkins, D. E., Wolen, A. R., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.11 · Cited by 100
Mosing, M. A., Gordon, S. D., Medland, S. E., Statham, D. J., Nelson, E. C., Heath, A. C., Martin, N. G., & Wray, N. R. (2009) · Depression and Anxiety · doi:10.1002/da.20611 · Cited by 99 · cited 1×
“Previous genetic epidemiology studies have shown that common genetic factors can underlie anxiety and depressive traits (42).”
BackgroundGelernter, J. E., Sun, N., Polimanti, R. A., Pietrzak, R. H., Levey, D. F., Lu, Q., Hu, Y., Li, B., Radhakrishnan, K., Aslan, M., et al. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2019.03.984 · Cited by 91
Self-citationTreating Anxiety in 2017: Optimizing Care to Improve Outcomes
Stein, M. B., & Craske, M. G. (2017) · JAMA · doi:10.1001/jama.2017.6996 · Cited by 85 · cited 1×
“Given their prevalence, associated impairment, and economic costs, anxiety disorders are a major public health concern (3).”
BackgroundSelf-citationDefective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome
Garone, C., D’Souza, A. R., Dallabona, C., Lodi, T., Rebelo‐Guiomar, P., Rorbach, J., Donati, M. A., Procopio, E., Montomoli, M., Guerrini, R., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx314 · Cited by 70
Nociceptin and the nociceptin receptor in learning and memory
Andero, R. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.02.007 · Cited by 39
Precision Psychiatry—Will Genomic Medicine Lead the Way?
Stein, M. B., & Smoller, J. W. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0375 · Cited by 33
Self-citationZareifopoulos, N., & Dylja, I. (2017) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2017.01.016 · Cited by 32
Kunzel, H. E., Ising, M., Zobel, A. W., Nickel, T., Ackl, N., Sonntag, A., Holsboer, F., & Uhr, M. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2004.06.006 · Cited by 31
A Major Role for Common Genetic Variation in Anxiety DisordersPreprint
Purves, K. L., Coleman, J. R. I., Meier, S. M., Rayner, C., Davis, K. A. S., Cheesman, R., Bækvad-Hansen, M., Børglum, A. D., Cho, S. W., Deckert, J., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/203844 · Cited by 27
Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation
Rekik, K., Silva, R. F. D., Colom, M., Pacifico, S., Zaveri, N. T., Calò, G., Rampon, C., Francès, B., & Moulédous, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.07.006 · Cited by 21
Cited by
Penninx, B. W., Pine, D. S., Holmes, E. A., & Reif, A. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00359-7 · Cited by 740
Levey, D. F., Stein, M. B., Wendt, F. R., Pathak, G. A., Zhou, H., Aslan, M., Quaden, R., Harrington, K. M., Nuñez, Y. Z., Overstreet, C., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-021-00860-2 · Cited by 422
Self-citationCandidate biomarkers in psychiatric disorders: state of the field
Abi‐Dargham, A., Moeller, S. J., Ali, F., DeLorenzo, C., Domschke, K., Horga, G., Jutla, A., Kotov, R., Paulus, M. P., Rubio, J. M., et al. (2023) · World Psychiatry · doi:10.1002/wps.21078 · Cited by 372
Als, T. D., Kurki, M. I., Grove, J., Voloudakis, G., Therrien, K., Tasanko, E., Nielsen, T. T., Naamanka, J., Veerapen, K., Levey, D. F., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02352-1 · Cited by 324
Self-citationEijsbouts, C., Zheng, T., Kennedy, N. A., Bonfiglio, F., Anderson, C. A., Moutsianas, L., Holliday, J., Shi, J., Shringarpure, S., 23andMe Research Team, et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00950-8 · Cited by 280
Metadata
- Authors
- Levey, D. F., Gelernter, J., Polimanti, R., Zhou, H., Cheng, Z., Aslan, M., Quaden, R., Concato, J., Radhakrishnan, K., Bryois, J., Sullivan, P. F., Program, T. M. V., & Stein, M. B.
- Venue
- American Journal of Psychiatry
- Published
- 2020-03-01
- Volume
- 177
- Issue
- 3
- Pages
- 223-232
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W3000587707
- Cited by
- 288
- References
- 64
- FWCI
- 22.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.